Validation of Chinese SRI Questionnaire

• Conditions: Chronic Obstructive Pulmonary Disease; Hypercapnic Respiratory Failure

• Registration Number: NCT02240225
• Lead Sponsor: Guangzhou Institute of Respiratory Disease

Brief Summary

Assessment of health-related quality of life in COPD patients with severe chronic respiratory failure requires appropriate and highly specific measurement tools. We attempt to validate the Chinese version of the Severe Respiratory Insufficiency Questionnaire (SRI)

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01
• Status Verified: 2014-09
• Study First Submitted: 2014-09-11
• Study First Submitted QC: 2014-09-11
• Last Update Submitted: 2014-09-11
• Study First Posted: 2014-09-15
• Last Update Posted: 2014-09-15
• Primary Completion: 2014-10
• Study Completion: 2014-10

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

1. Adult COPD Patients with chronic hypercapnic respiratory failure established on home noninvasive ventilation for at least 1 month
2. Patients are in a clinically stable state,without any changes of medication during the previous 4 weeks.

Exclusion Criteria

1. patient's refusal to participate
2. Patients with evidence of acute respiratory failure i.e.patients with worsening of symptoms during the previous 2 weeks, a pH ,7.35, or with signs of respiratory infection

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reliability of Severe Respiratory Insufficiency Questionnaire	2 weeks

Secondary Outcome Measures

Name	Time	Method
Criterion validity of Severe Respiratory Insufficiency Questionnaire	2 weeks
Construct validity of Severe Respiratory Insufficiency Questionnaire	2 weeks

Trial Locations

Locations (1)

Guangzhou Institute of Respiratory Disease; 🇨🇳 Guangzhou, Guangdong, China